Abstract
PURPOSE: Patients with Multiple Endocrine Neoplasia Type 1 (MEN1) are predisposed to develop duodenopancreatic neuroendocrine tumors (dpNETs) and metastatic dpNET is the primary cause of disease-related mortality. Presently, there is a paucity of prognostic factors that can reliably identify patients with MEN1-related dpNETS who are at high risk of distant
... read more